← Top stories
Deal▲ Bullish for Dr Lal PathLabs
Dr Lal PathLabs adds genomics heft with SN Genelab deal
The brief
- Dr Lal PathLabs added genomics capabilities through its deal with SN Genelab
- SN Genelab’s testing could gain wider reach through Dr Lal’s network, potentially boosting growth
- The deal may support growth at Dr Lal PathLabs, exposing its shareholders to genomics expansion